8-Methoxy-9-methyl-6,7,8,9-tetrahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6,7,16-triol
| Internal ID | a011844b-d450-44ca-93f7-496846c6a710 |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | (2R,3S,4R,5S,6S)-4,5-dihydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one |
| SMILES (Canonical) | CC12C(C(C(C(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)O)O)OC |
| SMILES (Isomeric) | C[C@]12[C@H]([C@@H]([C@@H]([C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)O)O)OC |
| InChI | InChI=1S/C27H23N3O5/c1-27-24(34-2)22(31)23(32)26(35-27)29-15-9-5-3-7-12(15)18-19-14(11-28-25(19)33)17-13-8-4-6-10-16(13)30(27)21(17)20(18)29/h3-10,22-24,26,31-32H,11H2,1-2H3,(H,28,33)/t22-,23+,24+,26+,27-/m1/s1 |
| InChI Key | CCOPBVQTBWBCIK-IKERNBKFSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C27H23N3O5 |
| Molecular Weight | 469.50 g/mol |
| Exact Mass | 469.16377084 g/mol |
| Topological Polar Surface Area (TPSA) | 97.90 Ų |
| XlogP | 2.00 |
| Atomic LogP (AlogP) | 3.10 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 3 |
| Rotatable Bonds | 1 |
| SCHEMBL2155183 |
| DTXSID20935204 |
| 8-Methoxy-9-methyl-6,7,8,9-tetrahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6,7,16-triol |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6617 | 66.17% |
| Caco-2 | - | 0.6873 | 68.73% |
| Blood Brain Barrier | - | 0.6500 | 65.00% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Mitochondria | 0.3863 | 38.63% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8694 | 86.94% |
| OATP1B3 inhibitior | + | 0.9473 | 94.73% |
| MATE1 inhibitior | - | 0.9200 | 92.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9654 | 96.54% |
| P-glycoprotein inhibitior | + | 0.6738 | 67.38% |
| P-glycoprotein substrate | + | 0.7834 | 78.34% |
| CYP3A4 substrate | + | 0.6826 | 68.26% |
| CYP2C9 substrate | - | 0.8006 | 80.06% |
| CYP2D6 substrate | - | 0.8820 | 88.20% |
| CYP3A4 inhibition | - | 0.6216 | 62.16% |
| CYP2C9 inhibition | - | 0.7997 | 79.97% |
| CYP2C19 inhibition | - | 0.7489 | 74.89% |
| CYP2D6 inhibition | - | 0.9097 | 90.97% |
| CYP1A2 inhibition | - | 0.5793 | 57.93% |
| CYP2C8 inhibition | + | 0.6434 | 64.34% |
| CYP inhibitory promiscuity | - | 0.6139 | 61.39% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.6441 | 64.41% |
| Eye corrosion | - | 0.9896 | 98.96% |
| Eye irritation | - | 0.9567 | 95.67% |
| Skin irritation | - | 0.7995 | 79.95% |
| Skin corrosion | - | 0.9453 | 94.53% |
| Ames mutagenesis | + | 0.6800 | 68.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.6546 | 65.46% |
| Micronuclear | + | 0.9000 | 90.00% |
| Hepatotoxicity | + | 0.5302 | 53.02% |
| skin sensitisation | - | 0.8873 | 88.73% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.8500 | 85.00% |
| Nephrotoxicity | + | 0.4688 | 46.88% |
| Acute Oral Toxicity (c) | III | 0.5887 | 58.87% |
| Estrogen receptor binding | + | 0.7295 | 72.95% |
| Androgen receptor binding | + | 0.5908 | 59.08% |
| Thyroid receptor binding | + | 0.5694 | 56.94% |
| Glucocorticoid receptor binding | + | 0.7446 | 74.46% |
| Aromatase binding | + | 0.7837 | 78.37% |
| PPAR gamma | + | 0.7901 | 79.01% |
| Honey bee toxicity | - | 0.7604 | 76.04% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | + | 0.5700 | 57.00% |
| Fish aquatic toxicity | - | 0.6615 | 66.15% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.35% | 91.11% |
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 98.90% | 81.14% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.47% | 85.14% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.85% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.54% | 94.45% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.12% | 95.56% |
| CHEMBL2581 | P07339 | Cathepsin D | 95.90% | 98.95% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 95.52% | 89.00% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 95.26% | 80.71% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 94.97% | 88.81% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 94.87% | 89.23% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 94.69% | 80.00% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 94.61% | 83.10% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 94.51% | 87.16% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 94.37% | 88.00% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 93.97% | 96.47% |
| CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 | 93.50% | 94.29% |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 | 93.09% | 96.64% |
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 | 92.44% | 91.83% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 92.23% | 99.23% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 91.63% | 95.64% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.55% | 95.89% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 91.50% | 84.49% |
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 | 91.45% | 90.48% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 91.25% | 97.03% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 90.90% | 80.00% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 90.74% | 94.00% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 90.67% | 91.96% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 90.59% | 85.11% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 90.32% | 83.65% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 90.26% | 91.79% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 89.97% | 93.03% |
| CHEMBL2292 | Q13627 | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | 89.80% | 93.24% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 88.58% | 96.00% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 87.99% | 91.07% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.49% | 95.83% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 87.02% | 96.00% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.70% | 86.33% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 86.62% | 97.14% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 86.37% | 90.08% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 85.86% | 85.30% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 85.79% | 98.59% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 85.76% | 90.95% |
| CHEMBL2535 | P11166 | Glucose transporter | 85.73% | 98.75% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 84.36% | 97.25% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 84.29% | 93.99% |
| CHEMBL4355 | O14976 | Serine/threonine-protein kinase GAK | 83.99% | 89.32% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 83.83% | 82.50% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 83.64% | 81.58% |
| CHEMBL2527 | O96017 | Serine/threonine-protein kinase Chk2 | 82.31% | 97.50% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 81.79% | 92.67% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 81.64% | 91.03% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.41% | 88.56% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 80.96% | 97.09% |
| CHEMBL4237 | O75582 | Ribosomal protein S6 kinase alpha 5 | 80.77% | 91.00% |
| CHEMBL1936 | P10721 | Stem cell growth factor receptor | 80.03% | 84.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 192702 |
| LOTUS | LTS0170010 |
| wikiData | Q77421030 |